Clinical Trials Directory

Trials / Completed

CompletedNCT03949036

Comparison of Two Different Preload Targets of Stroke Volume Variation During Kidney Transplantation

Comparison of Two Different Preload Targets of Stroke Volume Variation During Kidney Transplantation: A Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Seoul National University Hospital · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

The investigators sought to compare the effect of two preload targets of stroke volume variation of ≤6% and ≤12% on the postoperative renal function in patients undergoing living donor kidney transplantation. Goal-directed fluid therapy will be performed in both groups to maintain adequate stroke volume, stroke volume variation, mean arterial pressure (or systemic vascular resistance) during kidney transplantation. Only the preload target for giving crystalloid during surgery will be different between groups.

Detailed description

The adequate preload target of fluid management has not yet been established during kidney transplantation. Traditionally, sufficient intravascular volume status has been recommended to maintain perfusion to renal graft. Stroke volume variation was reported to be superior to the traditional target of central venous pressure. In this regard, the investigators sought to compare the effect of two preload targets of stroke volume variation of ≤6% and ≤12% on the postoperative renal function in patients undergoing living donor kidney transplantation. Goal-directed fluid therapy will be performed in both groups to maintain adequate stroke volume, stroke volume variation, mean arterial pressure (or systemic vascular resistance) during kidney transplantation. Only the preload target for giving crystalloid during surgery will be different between groups.

Conditions

Interventions

TypeNameDescription
OTHERCrystalloid fluid administration with the target of stroke volume variation ≤ 12%The rate of crystalloid fluid administration will be controlled to achieve the target of stroke volume variation ≤ 12%
OTHERCrystalloid fluid administration with the target of stroke volume variation ≤ 6%The rate of crystalloid fluid administration will be controlled to achieve the target of stroke volume variation ≤ 6%

Timeline

Start date
2019-05-01
Primary completion
2020-11-25
Completion
2020-11-25
First posted
2019-05-14
Last updated
2021-10-21

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT03949036. Inclusion in this directory is not an endorsement.